Article Listing - Catalonia's pharmaceutical spending dropped by 23.9% in November compared ...

FORTHCOMING MEETINGS FROM IBC

13 April 1992

IBC Technical Services Ltd is organizing the following industry-related conferences over the next few months:

- Strategies, Costs and Timing: The...

STRONG EXPANSION AT KNOLL IN 1991

13 April 1992

The drug-making arm of the German chemical concern BASF, Knoll AG, has reported a 9% expansion of sales worldwide...

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

Novo-Nordisk has launched four formulations of its recombinant human insulin under the trade name Mixtard HMge Penfill. All the formulations...

EC TRADEMARKS/ PATENTS CONGRESS

13 April 1992

The second European congress on patents, trademarks and innovation, Pattinova '92, is scheduled to take place May 18-20 in Lisbon,...

BIOCRAFT BOOSTED BY APPROVALS

13 April 1992

The US pharmaceutical concern Biocraft Laboratories has been boosted in the first quarter of the current year by approvals from...

GENZYME SEEKING EURO APPROVAL OF CEREDASE

13 April 1992

Presently approved in the USA as an enzyme replacement therapy for patients with Gaucher disease type I, Genzyme Corp's Ceredase...

IDEC PHARMA'S ANTIBODY THERAPY

13 April 1992

IDEC Pharmaceuticals reports that it has developed a "primatized" antibody which could improve the treatment of several chronic diseases. The...

PATENT INFRINGEMENT SUIT OVER SANDOZ' ZADITEN

13 April 1992

The Tokyo District Court has issued a preliminary injunction against Kyowa Yakuhin Kogyo, Tatsumi Kagaku and Ohara Yakuhin Kogyo with...

S-P HEALTHCARE PRODUCTS CANADA

13 April 1992

At Schering-Plough Health-Care Products Canada Inc, George Cugini moves up to vice president, marketing, from marketing director, seasonal products. Dan...

ISRAEL'S YISSUM R&D CO CLAIMS ACHIEVEMENTS

13 April 1992

Yissum is Israel's leading university R&D company, the Marketletter's local correspondent notes, and it offers more than 150 applied research...